Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Matsushita

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 27, 2002
Parallel and antiparallel dimers of magainin 2: their interaction with phospholipid membrane and antibacterial activityYasuhiro Mukai, Yuko Matsushita, Takuro Niidome, et al.
Brain Tumor Pathology|November 4, 2010
p53 abnormality and tumor invasion in patients with malignant astrocytomaHiroyuki Momota, Yoshitaka Narita, Yuko Matsushita, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasisKen Hashimoto, Yoshitaka Narita, Yuko Matsushita, et al.
Radiation Oncology (London, England)|November 14, 2019
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 yearsMakoto Ohno, Yasuji Miyakita, Masamichi Takahashi, et al.
Brain Tumor Pathology|March 16, 2013
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomasMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Journal of Microbiological Methods|March 1, 2015
Analysis of variations in band positions for normalization in across-gel denaturing gradient gel electrophoresisYuko Matsushita, Kohji Yamamura, Sho Morimoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2020
Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytomaKaishi Satomi, Makoto Ohno, Yuko Matsushita, et al.
Genes, Chromosomes & Cancer|January 30, 2022
Soft-tissue sarcoma with MN1-BEND2 fusion: A case report and comparison with astroblastomaAkihiko Yoshida, Kaishi Satomi, Eisuke Kobayashi, et al.
Histopathology|September 18, 2018
Frequent false-negative immunohistochemical staining with IDH1 (R132H)-specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosisAkihiko Yoshida, Kaishi Satomi, Makoto Ohno, et al.
Brain Tumor Pathology|February 22, 2023
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case reportHirokazu Sugino, Kaishi Satomi, Taisuke Mori, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 27, 2002
Parallel and antiparallel dimers of magainin 2: their interaction with phospholipid membrane and antibacterial activityYasuhiro Mukai, Yuko Matsushita, Takuro Niidome, et al.
Brain Tumor Pathology|November 4, 2010
p53 abnormality and tumor invasion in patients with malignant astrocytomaHiroyuki Momota, Yoshitaka Narita, Yuko Matsushita, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasisKen Hashimoto, Yoshitaka Narita, Yuko Matsushita, et al.
Radiation Oncology (London, England)|November 14, 2019
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 yearsMakoto Ohno, Yasuji Miyakita, Masamichi Takahashi, et al.
Brain Tumor Pathology|March 16, 2013
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomasMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Journal of Microbiological Methods|March 1, 2015
Analysis of variations in band positions for normalization in across-gel denaturing gradient gel electrophoresisYuko Matsushita, Kohji Yamamura, Sho Morimoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2020
Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytomaKaishi Satomi, Makoto Ohno, Yuko Matsushita, et al.
Genes, Chromosomes & Cancer|January 30, 2022
Soft-tissue sarcoma with MN1-BEND2 fusion: A case report and comparison with astroblastomaAkihiko Yoshida, Kaishi Satomi, Eisuke Kobayashi, et al.
Histopathology|September 18, 2018
Frequent false-negative immunohistochemical staining with IDH1 (R132H)-specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosisAkihiko Yoshida, Kaishi Satomi, Makoto Ohno, et al.
Brain Tumor Pathology|February 22, 2023
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case reportHirokazu Sugino, Kaishi Satomi, Taisuke Mori, et al.
Pageof 8